Furthermore, the studies using NLRP3–/–, ASC–/–, and caspase-1–/– mice suggest that the pathogenesis of NAFLD is associated with the activation of NLRP3 inflammasome (Henao-Mejia et al., 2012). Here, NLRP3 is linked to metabolic dysfunction-associated steatotic liver disease.